Prestige Consumer Healthcare Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for PBH, updated each market day.
PBH AI Sentiment
AI sees no strong directional signal for Prestige Consumer Healthcare Inc. stock over the next 10 market days.
Prediction date: June 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Sector
Exchange
Market Cap
$2,152,591,223
Cap Tier
Employees
890
Headquarters
TARRYTOWN, NY
Listed Since
Feb. 10, 2005
Website
PBH Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PBH Volatility
Prestige Consumer Healthcare Inc. has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
